What this study is
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
What's being tested
- Treatment as Usual
Intervention · OTHER
Peer-facilitated referral to a local primary care provider to follow-up their screening results.
- Telehealth-Cardiology
Intervention · OTHER
Peer-facilitated virtual consultation with cardiovascular specialist, for follow-up of their screening results. Activities may include: referral for a locally performed testing including echocardiogram and additional blood work, and transitional care management facilitated by a remote nurse care manager and the peer Referral for a locally performed testing including echocardiogram Transitional care management facilitated by a remote nurse care manager and the peer
Study details
- Sponsor
- Oregon Health and Science University
- Conditions
- Methamphetamine Use · Heart Failure
- Enrolling
- 200 people
- Starts
- 2024-08-19
- Est. completion
- 2029-06-30
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient-defined regular use of methamphetamine in the last year
- Any methamphetamine use in the past 30 days
- Age 18 years or older
- No client-reported diagnosis of heart failure
- Able to communicate in English
- Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms
You can't join if
- Self-reported engagement in medical care for heart failure in past 6 months.
- Actively taking medications for heart failure.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openOregon Health & Science University
Portland, Oregon, United States
- Brian Chan, MD, MPH · Contact503-494-2010chanbri@ohsu.edu
Recruiting
Study team
Sponsor
Oregon Health and Science University
Study ID STUDY00026150
Principal investigator
Brian Chan, MD, MPH
Oregon Health and Science University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.